Position in JAZZ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$96,439,085
+$92,733,705 QoQ
Shares Held
400,212
+1941.9% QoQ
Ownership
0.617%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#35
of 640 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Derivatives in JAZZ
reported options exposure · as of Dec 31, 2021CallValue
$917,280
CallShares
7,200
PutValue
$1,732,640
PutShares
13,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. JAZZ ranks #21 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in JAZZ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $96,439,085 | 400,212 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,705,380 | 19,600 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $408,000 | 2,400 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $550,001 | 4,173 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,787,285 | 45,112 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $42,758,873 | 344,413 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $23,044,566 | 187,126 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $35,663,566 | 320,111 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,968,902 | 93,403 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,365,721 | 94,384 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,701,163 | 54,481 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,595,120 | 35,500 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $18,109,165 | 146,077 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $12,553,065 | 85,786 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $38,165,578 | 239,568 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,465,215 | 33,500 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $14,548,868 | 93,256 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $917,280 | 7,200 | Call | Sole | 2022-02-14 | |
| 2021-12-31 | $1,732,640 | 13,600 | Put | Sole | 2022-02-14 | |
| 2021-09-30 | $5,052,148 | 38,800 | Put | Sole | 2021-11-15 | |
| 2021-09-30 | $3,893,279 | 29,900 | Call | Sole | 2021-11-15 | |
| 2021-06-30 | $13,084,607 | 73,658 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $40,498,959 | 246,389 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $947,367 | 6,644 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $28,703,626 | 260,138 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||